About BIOVALENCE SDN. BHD.

Biovalence S/B was formed in 2011 after winning a Gold Award at BioMalaysia 2011 for pharmaceutical innovation. Our platform technology is the RetroMAD1 broad spectrum antiviral protein that has been tested successfully on over 20 different viruses in fishes, shrimp, cats, dogs, monkeys and even minks. We are located in Petaling Jaya and we are one of Malaysia’s top biologic research and development companies with engagements with many multinationals and international research groups. Our mission is to develop cost-effective broad spectrum antiviral proteins for the betterment of mankind, his pets and his livestock. Our staff members are mainly from a variety of life science disciplines, and are led by a Chairman and a CTO who have both spent over 30+ years in various aspects of the life science industries locally and abroad. For more information please visit http://biovalence.com.my/